STS Lung Metastasectomy — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Pulmonary metastasectomy may be curative in selected STS patients — criteria: complete resection of all pulmonary disease technically feasible, controlled primary, no extrapulmonary disease, adequate respiratory reserve and prolonged disease-free interval
Pulmonary metastasectomy is an established curative-intent intervention for selected STS patients with lung-limited metastatic disease. Favourable prognostic factors: complete resection (R0), ≤3 lesions, prolonged disease-free interval (>12-18 months), absence of extrapulmonary disease, low-grade histology and good response to preoperative chemotherapy. Five-year OS after complete metastasectomy is approximately 30-40%. The International Registry of Lung Metastases provides the largest dataset supporting this approach.
Reference: ESMO 2024 STS; NICE; International Registry of Lung Metastases; Pastorino et al J Thorac Cardiovasc Surg 1997